View Older Stories View More Recent Stories
-
Humana (HUM) Loses Medicare Bonus Payment Lawsuit - Bloomberg
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.9% Yield
-
TD Cowen on CVS Health (CVS): 'CNC's Pain Could Be CVS's Gain'
-
CVS Health (CVS) call put ratio 1.4 calls to 1 put
-
CVS Health (CVS) opens new WITC in Chicago
-
Cantor Fitzgerald Upgrades CVS Health (CVS) to Overweight
-
Medicare Pharmacy Benefit Manager Limits Stripped From Tax Bill - Bloomberg
-
Medicare Surfaces as Target for Cuts to Pay for Trump Tax Bill'- Bloomberg
-
Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Cantor Fitzgerald says CMS' new audit strategy has logistical challenges
-
Keybanc: 'CMS Expanding RADV Audits, MA Can't Catch a Break'
-
After-hours movers: Snowflake, Urban Outfitters, CVS Health
-
UnitedHealth (UNH), Others Lower as CMS Will Expand Audits Of Medicare Advantage Plans
-
Takeaways from UBS's 2025 Healthcare Insurance Symposium
-
CVS Health (CVS) call put ratio 1 call to 2.6 puts as share price down 1.2%
-
Bernstein: 'We See the Reaction to PBM Stocks as Off Target'
-
CVS Health (CVS), Others Fall After Trump Said Will Cut out Middle Man on Drugs
-
CVS Health (CVS) PT Raised to $86 at JPMorgan
-
Glenview Capital Issues Statement on CVS Health (CVS)
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Novo Nordisk shares jump as FDA accepts oral Wegovy application
-
CVS Health (CVS) Evercore Removes Two Names from TAP Outperform List
-
CVS Health (CVS) Tops Q1 EPS by 61c; raises guidance
-
CVS Health (CVS) call put ratio 4 calls to 1 put with a focus on May 2 weekly 67 calls
-
CVS Health (CVS) May 2 weekly 65 straddle priced into quarter results
-
Truist Securities Reiterates Buy Rating on CVS Health (CVS) Amid CFO Transition
-
TD Cowen Reiterates Buy Rating on CVS Health (CVS); 'MA Final Rate Notice Positive'
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
BofA Securities Reiterates Buy Rating on CVS Health (CVS)
-
Leerink Partners Reiterates Outperform Rating on CVS Health (CVS)
-
CVS Health (CVS) Appoints Brian Newman as CFO, Amy Compton-Phillips as Chief Medical Officer
-
After-hours movers: Broadcom, Levi, Human and more
-
Trump Administration Medicare Insurer Rate Increase Doubles Prior Proposal -- WSJ
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.9% Yield
-
BofA Positive on UnitedHealth Group (UNH) and CVS (CVS) Reserves Positions, Negative on Humana (HUM)
-
Bernstein on Value Based Care Sector: 'We See an Attractive Set Up'
-
CVS Health (CVS) PT Raised to $70 at Mizuho
-
Wellvana acquires CVS Health's (CVS) MSSP business
-
CVS Health (CVS) enhances flu testing and treatment, offers at-home testing
-
Humana (HUM) Trades Lower in Sympathy with UnitedHealth Group (UNH)
-
CVS Health (CVS) PT Raised to $71 at Bernstein on 'Greater Confidence in Jump Off Point in Aetna Earnings'
-
Thermo Fisher Scientific (TMO) Appoints Karen S. Lynch to its Board
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
CVS Health (CVS) PT Raised to $75 at Raymond James
-
CVS Health (CVS) PT Raised to $76 at Truist Securities
-
CVS Health (CVS) PT Raised to $75 at BofA Securities
-
Leerink Partners Upgrades CVS Health (CVS) to Outperform
